Citi Opens Catalyst Watch on Summit Therapeutics plc (SMMT) Feb 24, 2026 05:15AM
Summit Therapeutics to Present at Upcoming Investor Conferences Nov 4, 2025 07:00AM
Citizens Highlights Summit’s (SMMT) Ivonescimab Superiority, Reiterates at Outperform Oct 20, 2025 09:50AM
Citi Opens 30-Day Upside Catalyst Watch on Summit Therapeutics plc (SMMT) Sep 25, 2025 04:14AM
Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT) Sep 10, 2025 04:18AM


Sep 8, 2025 04:20AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
Aug 19, 2025 04:29AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
Jun 2, 2025 04:07AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025
May 28, 2025 04:25AM Citizens JMP shares updates on cancer treatment stocks
Apr 28, 2025 05:35AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
Apr 21, 2025 04:25AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
Mar 26, 2025 05:01AM Citi Upgrades Summit Therapeutics plc (SMMT) to Buy
Nov 26, 2024 04:15PM Summit Therapeutics to Present at Upcoming Investor Conferences
Sep 27, 2024 05:29AM Citi Downgrades Summit Therapeutics plc (SMMT) to Neutral, 'Valuation Looking Fair for Now'
Sep 27, 2024 05:29AM Citi Downgrades Summit Therapeutics plc (SMMT) to Neutral, 'Valuation Looking Fair for Now'
Sep 9, 2024 05:03AM Summit Therapeutics plc (SMMT) PT Raised to $19 at Citi
Jul 19, 2024 05:14AM Citi Opens 90-Day Upside Catalyst Watch on Summit Therapeutics plc (SMMT)
Jun 4, 2024 09:41AM Citi Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
May 31, 2024 06:58AM Summit Therapeutics plc (SMMT) PT Raised to $13 at Citi
May 7, 2024 05:12AM Citi Starts Summit Therapeutics plc (SMMT) at Buy, Opens 90-Day Positive Catalyst Watch